Andrew Stewart Plump, President, R&D at TAKEDA PHARMACEUTICAL CO LTD (TAK), sold 19,651 shares at $18.49 ($363K) on 2026-08-19, disclosed to the SEC on 2026-08-21.
Scheduled sale ($363k) by President, R&D under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |